Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Designing of Potential Polyvalent Vaccine Model for Respiratory Syncytial Virus by System Level Immunoinformatics Approaches.

BioMed research international - 1 Jan 2021

Naqvi Syeda Tahira Qousain, Yasmeen Mamoona, Ismail Mehreen, Muhammad Syed Aun, Nawazish-I-Husain Syed, Ali Amjad, Munir Fahad, Zhang QiYu

Abstract excerpt

BACKGROUND: Respiratory syncytial virus (RSV) infection is a public health epidemic, leading to around 3 million hospitalization and about 66,000 deaths each year. It is a life-threatening condition exclusive to children with no effective treatment. METHODS: In this study, we used system-level and vaccinomics approaches to design a polyvalent vaccine for RSV, which could stimulate the immune components of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens
Share to Epitopes, T-Lymphocyte

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hospitalization

Share to Immune System

Share to Respiratory Syncytial Virus, Human

Share to Respiratory Syncytial Virus Infections

Share to Vaccines

Share to Viral Fusion Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 34136576
DOI: 10.1155/2021/9940010
PMCID: PMC8177976

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Designing of Potential Polyvalent Vaccine Model for Respiratory Syncytial Virus by System Level Immunoinformatics Approaches.PMID 34136576Read ↗

Exploring different virulent proteins of human respiratory syncytial virus for designing a novel epitope-based polyvalent vaccine: Immunoinformatics and molecular dynamics approachesSemantic proximity Read ↗

Multiepitope-Based Subunit Vaccine Design and Evaluation against Respiratory Syncytial Virus Using Reverse Vaccinology ApproachSemantic proximity Read ↗

The multi-epitope vaccine prediction to combat Pandemic SARS-CoV-2, an immunoinformatic approachSemantic proximity Read ↗

Designing a T cell multi-epitope vaccine against hRSV with reverse vaccinology: an immunoinformatics approachSemantic proximity Read ↗

Designing spike protein (S-Protein) based multi-epitope peptide vaccine against SARS COVID-19 by immunoinformaticsSemantic proximity Read ↗

Strategies for vaccine design for corona virus using Immunoinformatics techniquesSemantic proximity Read ↗

Immunoinformatics-aided rational design of multiepitope-based peptide vaccine (MEBV) targeting human parainfluenza virus 3 (HPIV-3) stable proteinsSemantic proximity Read ↗

Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopesSemantic proximity Read ↗

Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniquesSemantic proximity Read ↗

Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain: <i>In silico</i> analysisSemantic proximity Read ↗

Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysisSemantic proximity Read ↗

Genome based Evolutionary study of SARS-CoV-2 towards the Prediction of Epitope Based Chimeric VaccineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.